Inaktiver Wert

Andere Sprachen Nymox Pharmaceutical Corporation Nasdaq

Aktien

CA67076P1027

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

2023	Nymox Pharmaceutical Corporation meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI
2023	Nymox Pharmaceutical Corporation kündigt Einreichung eines neuen Zulassungsantrags für NYMOZARFEX (TM) zur Behandlung von BPH an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages	27.03.
OTC F-Stocks Holiday Momentum Watchlist (TBRIF, PYRGF, NYMXF, MGDPF)	28.12.
Nymox December 27 Message to Shareholders	27.12.
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others	30.11.
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court	21.11.
Nymox: Q3 Earnings Snapshot	15.11.
Nymox Pharmaceutical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15.11.
Nymox Pharmaceutical : MANAGEMENT’S DISCUSSION AND ANALYSIS - Form 6-K	15.11.
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million	09.11.
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized	03.11.
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	03.11.
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023	03.11.
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations	02.11.
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting	31.10.23
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting	27.10.23
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review	26.10.23
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	25.09.23
Nymox Pharmaceutical Corporation Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH	25.09.23
Nymox Reports Completion of $2 Million Private Placement	29.08.23
Nymox Pharmaceutical Corporation announced that it has received $2 million in funding	29.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Nymox Pharmaceutical Corporation Nasdaq

Aktien

CA67076P1027

Andere Sprachen

Filter